Literature DB >> 15355825

Assessing the effect of low dose dobutamine on various diastolic function indexes.

Sevket Görgülü1, Mehmet Eren, Bülent Uzunlar, Hüseyin Uyarel, Tuna Tezel.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the effect of low dose dobutamine (LDD) on various diastolic function parameters in patients without wall motion abnormality.
METHODS: Thirty-one volunteer patients who had no regional wall motion abnormality were included in the study. Echocardiographic measurements were taken both at pre-dobutamine and during LDD infusion. The peak E velocity, A velocity, the E/A ratio, deceleration time (DT), isovolumetric relaxation time (IVRT), myocardial performance index (MPI) and flow propagation velocity (FPV) were assessed as left ventricular diastolic function parameters. Tissue Doppler velocities were also obtained in order to calculate the E/Em and Em/Am ratios.
RESULTS: No significant changes were observed in heart rate, E velocity, A velocity, E/A ratio, E/Em ratio, Em/Am ratio, systolic and diastolic blood pressure with LDD. With LDD, DT (239+/-40 ms vs. 201+/-31 ms, p<0.001), IVRT (109+/-12 ms vs. 94+/-11 ms, p<0.001) and MPI (0.57+/-0.15 vs. 0.44+/-0.22, p<0.001) were found to be decreased, while there was an increase in FPV (45+/-8 cm/s vs. 59+/-10 cm/s, p<0.001) and ejection fraction (64+/-6% vs. 66+/-7%, p<0.05).
CONCLUSION: Low dose dobutamine (5 mcg/kg of body weight) improves left ventricular relaxation in patients with normal wall motion, while it has no effect on left ventricular filling pressure index.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15355825

Source DB:  PubMed          Journal:  Anadolu Kardiyol Derg        ISSN: 1302-8723


  1 in total

1.  Effects of a single, 24-hour, low-dose intravenous dobutamine infusion on left ventricular myocardial performance index in congestive heart failure: A prospective, nonrandomized study.

Authors:  Melek Ulucam; Mehmet Emin Korkmaz; Haldun Muderrisoglu; Bulent Ozin; Aylin Yildirir; Egemen Tayfun; Alp Aydinalp
Journal:  Curr Ther Res Clin Exp       Date:  2005-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.